Skip to main content
Livermore
Livermore
ZHEN

US Bancorp

SEC CIK
0000036104
Latest filing
Aug 12, 2026

BTAIQ holding history

BioXcel Therapeutics, Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BTAIQ overviewAll 13F holders of BTAIQFull Q2 2026 holdings

Shares (Q2 2026)
1
Value
$1
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of BTAIQ by US Bancorp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261$1<0.1%00.0%UnchangedHolders
Q1 20261$1<0.1%00.0%UnchangedHolders
Q4 20251$2<0.1%00.0%UnchangedHolders
Q3 20251$3<0.1%00.0%UnchangedHolders
Q2 20251$2<0.1%00.0%UnchangedHolders
Q1 20251$2<0.1%−1−51.5%ReducedConverted for a 1-for-16 splitHolders
Q4 202433$12<0.1%−18,000−99.8%ReducedHolders
Q3 202418,033$11.0K<0.1%−435−2.4%ReducedHolders
Q2 202418,468$23.6K<0.1%+435+2.4%AddedHolders
Q1 202418,033$50.9K<0.1%00.0%UnchangedHolders
Q4 202318,033$53.2K<0.1%00.0%UnchangedHolders
Q3 202318,033$45.6K<0.1%+3,961+28.1%AddedHolders
Q2 202314,072$93.7K<0.1%+14,039+42,542.4%AddedHolders
Q1 202333$616<0.1%00.0%UnchangedHolders
Q4 202233$709<0.1%−382−92.0%ReducedHolders
Q3 2022415$5.00K<0.1%−196−32.1%ReducedHolders
Q2 2022611$8.00K<0.1%−106−14.8%ReducedHolders
Q1 2022717$15.0K<0.1%−110−13.3%ReducedHolders
Q4 2021827$17.0K<0.1%−223−21.2%ReducedHolders
Q3 20211,050$32.0K<0.1%−348−24.9%ReducedHolders
Q2 20211,398$41.0K<0.1%−3,518−71.6%ReducedHolders
Q1 20214,916$212.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.